The Susan Wojcicki Foundation launched Tuesday with USD$150 million to improve lung cancer detection and prevention worldwide.
The organization emerged after former YouTube chief executive Susan Wojcicki received a late-stage lung cancer diagnosis in 2022. Additionally, the foundation plans to unite leaders in science, healthcare and technology to improve how doctors identify people at risk for the disease.
Lung cancer remains the world’s deadliest cancer and causes roughly 1.8 million deaths annually. However, survival rates improve significantly when doctors detect the disease earlier.
The foundation said lung cancer demographics are also shifting. Increasingly, younger people, women and individuals who never smoked are receiving diagnoses. Furthermore, the disease has become more common among women of Asian descent.
The Troper and Wojcicki families committed USD$150 million to establish the organization. Additionally, the foundation secured several multi-million-dollar commitments to support first-year programs and long-term growth initiatives.
Among those contributions, Google.org will fund projects using artificial intelligence to improve lung cancer risk detection and earlier diagnosis. Meanwhile, philanthropist Melinda French Gates and enterprise software company Salesforce Inc. (NYSE: CRM) also contributed funding at launch.
The foundation also plans to expand public awareness campaigns around lung cancer. Additionally, it intends to work with YouTube and YouTube Health alongside online creators to reach broader audiences.
Susan Wojcicki’s husband Dennis Troper said the initiative carries deep personal meaning for the family. He said the foundation wants to support researchers, clinicians, advocates and creators working to improve outcomes for patients.
Troper also said the organization hopes to accelerate progress in early detection technologies while helping families facing the disease.
Read more: Prestigious medtech intelligence firm recognizes Breath Diagnostics for innovation
Read more: Breath Diagnostics completes install of advanced mass spectrometry system
Organization plans collaboration with cancer groups
The foundation assembled leadership teams spanning medicine, science, education and philanthropy. Additionally, Susan Wojcicki’s sisters Janet Wojcicki and Anne Wojcicki joined the organization alongside Troper.
Scientific advisory groups will focus on diagnostics, clinical research and emerging technologies. Meanwhile, separate patient and creator councils will help guide outreach and communication strategies.
The organization also plans to collaborate with several established cancer groups. These include Stand Up To Cancer and the Lung Cancer Research Foundation. Furthermore, the foundation partnered with more than 20 advocacy organizations through the Lung Cancer Genetics Study initiative.
Participating advocacy groups include GO2 for Lung Cancer, LUNGevity Foundation and Lung Cancer Foundation of America. Additionally, the initiative aims to improve understanding of lung cancer genetics and risk factors.
Foundation executive director Dr. Nadia Litterman said too many patients still receive diagnoses at later stages. She also said Susan Wojcicki believed strongly in connecting experts from different industries to solve difficult problems.
Litterman added that researchers and innovators now have an opportunity to accelerate the development of earlier detection tools. Consequently, the foundation hopes those technologies can reach patients sooner.
“We are at a remarkable moment where advances in science, technology, and philanthropy are converging in ways that could fundamentally change the future of lung cancer,” said Litterman.
“The time is now. There is real momentum behind earlier detection and prevention, and with continued collaboration across sectors, we can move closer to a world where far fewer families experience the loss of a loved one to this disease.”
.
joseph@mugglehead.com
